Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Harin Padma Nathan"'
Autor:
Ford, Kanti, Spigarelli, Michael G.
Publikováno v:
In Journal of Pediatric and Adolescent Gynecology 2006 19(5):360-360
Autor:
Manna Molecular Science
Publikováno v:
Business Wire (English). 12/04/2018.
Publikováno v:
The Journal of Sexual Medicine. 5:476-484
Introduction After bilateral nerve-sparing radical retropubic prostatectomy (BNSRRP), nocturnal and sexually mediated erections may help to preserve normal erectile function (EF). Aim To investigate nocturnal penile tumescence and rigidity (NPTR) in
Autor:
Harin Padma‐Nathan, Francesco Montorsi, François Giuliano, Eric Meuleman, Stephen Auerbach, Ian Eardley, Andrew McCullough, Martin Homering, Thomas Segerson, null for the North American and European Vardenafil Study Group
Publikováno v:
The Journal of Sexual Medicine. 4:152-161
The ability of oral phosphodiesterase type 5 (PDE5) inhibitor therapy to restore erectile function to normal is an important attribute to men with erectile dysfunction (ED).To assess the ability of vardenafil to restore normal erectile function in me
Autor:
Harin Padma-Nathan, James L. Yeager
Publikováno v:
Urology. 68:386-391
Objective To assess the safety and efficacy of topical alprostadil cream for erectile dysfunction (ED). Methods Patients with an ED score of 25 or less on the erectile function domain of the International Index of Erectile Function (IIEF) were random
Autor:
Harin Padma-Nathan
Publikováno v:
International Journal of Impotence Research. 18:423-431
In the 7 years since sildenafil citrate (VIAGRA) was introduced as the first oral phosphodiesterase type 5 inhibitor therapy for erectile dysfunction, it has been used to treat nearly 27 million men with erectile dysfunction worldwide. Patient popula
Publikováno v:
Current Urology Reports. 5:467-471
Postprostatectomy erectile dysfunction appears to be initiated by neuropraxia and perpetuated by cavernosal smooth muscle apoptosis. Phosphodiesterase-5 (PDE-5) inhibitor therapy is the current cornerstone of erectile dysfunction (ED) therapy in this
Autor:
Manfred Beneke, Hartwig Schwaibold, Harin Padma-Nathan, Tiemo-Joerg Bandel, Hartmut Porst, Ernst Ulbrich, Jacques Buvat, Francesco Montorsi
Publikováno v:
The Journal of Sexual Medicine. 1:168-178
Introduction. Vardenafil, a potent and selective oral PDE5 inhibitor, is efficacious and generally well-tolerated in men with erectile dysfunction (ED). Of considerable interest to patients and physicians is an understanding of the time required afte
Autor:
Raymond C. Rosen, Harin Padma-Nathan, Vish Watkins, William Pullman, Khalil Saikali, Ridwan Shabsigh
Publikováno v:
The Journal of Sexual Medicine. 1:193-200
Introduction Tadalafil is a phosphodiesterase 5 (PDE5) inhibitor used for the treatment of erectile dysfunction (ED). The minimal time to onset of erectogenic effect in the at‐home setting has not been evaluated. Aim The goal was to determine the e
Autor:
Harin, Padma-Nathan, George, Christ, Ganesan, Adaikan, Edgardo, Becher, Gerald, Brock, Serge, Carrier, Culley, Carson, Jackie, Corbin, Sharon, Francis, Robert, DeBusk, Ian, Eardley, Hans, Hedlund, Adolph, Hutter, Graham, Jackson, Robert, Kloner, Ching-Shwun, Lin, Shin, Lin, Kevin, McVary, Andrew, McCullough, Ajay, Nehra, Hartmut, Porst, Claude, Schulman, Allen, Seftel, Ira, Sharlip, Christian, Stief, Claude, Teloken
Publikováno v:
The Journal of Sexual Medicine. 1:128-140
Summary of Committee. For the complete report please refer to Sexual Medicine: Sexual Dysfunctions in Men and Women, edited by T.F. Lue, R. Basson, R. Rosen, F. Giuliano, S. Khoury, F. Montorsi, Health Publications, Paris 2004. ABSTRACT Introduction.